Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOSE Study: Methadone Dosing for Pain in OUD
NCT05459402Phase 3Recruiting
- Sponsor
- University of Maryland, Baltimore
- Start
- Feb 2023
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methadone in opioid use disorder (OUD), chronic pain, sponsored by University of Maryland, Baltimore. Started Feb 2023; status: recruiting.
02
Drugs
methadone
03
Conditions
opioid use disorder (OUD)chronic pain
Beyond the preview
Go deeper on NCT05459402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05459402.